Related Experiment Video
Updated: Sep 26, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
COVID-19 death and kidney disease in a multiracial Asian country
Bak Leong Goh1,2, Malini Shanmuganathan1, Kalaiarasu Peariasamy3
1Clinical Research Centre, Hospital Serdang, Kajang, Selangor, Malaysia.
Insights
Predictors of death in COVID-19 patients include older age, Chinese ethnicity, diabetes, and kidney disease. Hospital resources also impact mortality, highlighting disparities in care.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- COVID-19 infection poses significant mortality risks, particularly for patients with kidney disease (KD).
- Identifying predictors of mortality and KD is crucial for improving patient outcomes and management strategies.
Purpose of the Study:
- To identify predictors of death and acute kidney injury (AKI) in hospitalized COVID-19 patients.
- To analyze the influence of patient demographics, comorbidities, and healthcare center capacity on mortality and AKI.
Main Methods:
- Prospective, multicentre observational study.
- Inclusion of 6078 hospitalized COVID-19 patients from January to June 2020 in a multiracial Asian country.
- Statistical analysis to identify significant predictors of death and AKI after covariate adjustment.
Main Results:
- Overall case fatality rate (CFR) was 1.3%; however, patients with KD had a CFR of 20%.
- Significant predictors of death included advanced age (>70 years), Chinese ethnicity, diabetes mellitus (DM), and KD.
- Adjusted predictors for AKI were age (>51 years), DM, and disease severity at presentation. Chinese ethnicity was associated with a 2.58-fold increased risk of death compared to Malay.
- Center capacity for management, ventilation, and dialysis significantly influenced patient mortality.
Conclusions:
- Both patient-specific factors and healthcare center capacity are significant determinants of death and AKI in COVID-19 patients.
- The study highlights racial disparities in mortality rates and variations in outcomes based on healthcare resource availability within a multiracial Asian setting.
Introduction:
COVID-19 infection and kidney disease (KD) carry a considerable risk of mortality. Understanding predictors of death and KD may help improve management and patient outcome.
Methods:
This is a prospective multicentre observational study conducted in a multiracial Asian country to identify predictors of death and acute kidney injury (AKI) in hospitalized COVID-19 patients from January to June 2020.
Results:
A total of 6078 patients were included in this study. Mean age was 37.3 (±16.8) years, 71% were male, 59.4% Malay, 6.7% Chinese, 2.3% Indian and 31.7% other ethnicities. AKI was seen in 3.5% of patients while 1.6% had pre-existing chronic kidney disease (CKD). Overall case fatality rate (CFR) was 1.3%. Patients with KD (AKI and CKD) had CFR of 20%. Many factors were associated with increased risk of death and AKI. However, significant predictors of death after adjustment for covariates were age (>70 years), Chinese ethnicity, diabetes mellitus (DM) and KD. Adjusted predictors of AKI were age (>51 years), DM and severity at presentation. Chinese were 2.58 times more likely to die (p = .036) compared to Malay. Centre capacity to manage, ventilate and dialyze patients significantly influenced death. Among those with AKI, the most common symptoms were fever, cough, and dyspnea. They had lower absolute lymphocyte count, were more likely to be admitted to ICU, required more ventilation and longer hospitalization.
Conclusion:
Patient and centre factors influence death and AKI among COVID-19 patients. This study also demonstrates death disparities across different racial groups and centre capacities in this multiracial Asian country.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology

